Work

Targeting the C5 subclass of high-grade serous ovarian cancer using patient-derived xenografts: Microtubule polymerisation inhibitors.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.e22202

Authors: Valerie Heong, Monique Topp, Sumitra Ananda, Orla McNally, Geoffrey John Lindeman, Paul Haluska, Matthew Wakefield, Elizabeth M. Swisher, David SP Tan, Huang Ruby, David Bowtell, Clare L. Scott

Institutions: Royal Women's Hospital, Walter and Eliza Hall Institute of Medical Research, The Royal Melbourne Hospital, Mayo Clinic, University of Washington, National University Cancer Institute, Singapore, National University of Singapore, Cancer Science Institute of Singapore, Peter MacCallum Cancer Centre

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2892660744

Cites:

Cited by: 1

Related to: 10